phenylalanine has been researched along with African Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, SA; Goepel, JR; Goyns, MH; Rees, RC; Zubair, AC | 1 |
| Fukushima, P; Guedez, L; Mansoor, A; Stetler-Stevenson, M; Stetler-Stevenson, WG; Wang, J; Wolff, L | 1 |
2 other study(ies) available for phenylalanine and African Lymphoma
| Article | Year |
|---|---|
Investigation of the effect of BB-94 (batimastat) on the colonization potential of human lymphoma cells in SCID mice.
Topics: Animals; Antineoplastic Agents; Burkitt Lymphoma; DNA; DNA, Neoplasm; Humans; Mice; Mice, SCID; Phenylalanine; Species Specificity; Thiophenes; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1996 |
In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.
Topics: Apoptosis; B-Lymphocytes; bcl-X Protein; Burkitt Lymphoma; Cells, Cultured; Depression, Chemical; Enzyme Inhibitors; Humans; Hyperplasia; Neoplastic Stem Cells; NF-kappa B; Palatine Tonsil; Phenylalanine; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Thiophenes; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Tumor Cells, Cultured | 1998 |